PML-IRIS in patients with HIV infection

Background: Progressive multifocal leukoencephalopathy (PML) is an opportunistic infection that develops in immunosuppressed patients with HIV infection. Paradoxically, some of these patients may develop PML during combined antiretroviral therapy in the setting of immune reconstitution. We describe the types of PML in relation to immune reconstitution inflammatory syndrome (IRIS) and the effects of steroid use in these patients. Methods: We performed a retrospective review of the literature (1998 to 2007) and of all HIV-infected patients diagnosed with PML-IRIS at Johns Hopkins Hospital (2004 to 2007). We recorded information on clinical features, microbiologic and virological analysis, neuroimaging, pathology, treatment, and outcome. Results: Of 54 patients with PML-IRIS, 36 developed PML and IRIS simultaneously (PML-s-IRIS) and 18 had worsening of preexisting PML (PML-d-IRIS) after the initiation of combined antiretroviral therapy. PML-IRIS developed between 1 week and 26 months after initiation of antiretroviral therapy. PML-d-IRIS patients developed IRIS earlier, had higher lesion loads on MRI of the brain, had shorter durations of survival, and had higher mortality rate compared to PML-s-IRIS patients. Twelve patients received treatment with steroids, of which five died and seven showed good neurologic recovery. Patients who survived had received steroids early after IRIS diagnosis for longer durations and had contrast enhancement on IRIS neuroimaging. Conclusions: Immune reconstitution following initiation of combined antiretroviral therapy may lead to activation of an inflammatory response to detectable or latent JC virus infection. Early and prolonged treatment with steroids may be useful in these patients but requires further investigation.

[1]  G. Breton.  [Immune reconstitution inflammatory syndrome]. , 2011, Bulletin de l'Academie nationale de medecine.

[2]  A. Lazzarin,et al.  The good and evil of HAART in HIV-related progressive multifocal leukoencephalopathy , 2011, Journal of NeuroVirology.

[3]  A. Lazzarin,et al.  The effect of highly active antiretroviral therapy-induced immune reconstitution on development and outcome of progressive multifocal leukoencephalopathy: Study of 43 cases with review of the literature , 2011, Journal of NeuroVirology.

[4]  R. D. Pasquier,et al.  Inflammatory reaction in progressive multifocal leukoencephalopathy: Harmful or beneficial? , 2011, Journal of NeuroVirology.

[5]  S. Croul,et al.  Detection of JC virus DNA fragments but not proteins in normal brain tissue , 2008, Annals of neurology.

[6]  R. Reimer,et al.  Activation of the glucocorticoid receptor releases unstimulated PBMCs from an early block in HIV-1 replication. , 2008, Virology.

[7]  K. Nagashima,et al.  [Case of highly active anti-retroviral therapy-induced immune reconstitution inflammatory syndrome in AIDS-related progressive multifocal leukoencephalopathy]. , 2007, Rinsho shinkeigaku = Clinical neurology.

[8]  S. Sarkar,et al.  Immune reconstitution after potent antiretroviral therapy in AIDS patients with progressive multifocal leukoencephalopathy , 2007, Scandinavian journal of infectious diseases.

[9]  G. Sevlever,et al.  Immune reconstitution inflammatory syndrome associated with PML in AIDS: A treatable disorder , 2006, Neurology.

[10]  J. McArthur,et al.  Therapy Insight: CNS manifestations of HIV-associated immune reconstitution inflammatory syndrome , 2006, Nature Clinical Practice Neurology.

[11]  I. Koralnik.  Progressive multifocal leukoencephalopathy revisited: Has the disease outgrown its name? , 2006, Annals of neurology.

[12]  Matthew A. Meier,et al.  Immune reconstitution syndrome in HIV: validating a case definition and identifying clinical predictors in persons initiating antiretroviral therapy. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[13]  Marcus Tulius T Silva,et al.  Inflammatory progressive multifocal leukoencephalopathy after antiretroviral treatment. , 2006, AIDS.

[14]  M. Maschke,et al.  Evolution of purely infratentorial PML under HAART—negative outcome under rapid immune reconstitution , 2005, Clinical Neurology and Neurosurgery.

[15]  C. Lehmann,et al.  AIDS-related progressive multifocal leukoencephalopathy in the era of HAART: report of two cases and review of the literature. , 2005, AIDS patient care and STDs.

[16]  A. Tunkel.  Dexamethasone for treatment of tuberculous meningitis in adolescents and adults , 2005, Current infectious disease reports.

[17]  E. Graviss,et al.  Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy , 2005, AIDS.

[18]  F. Gray,et al.  Fulminant inflammatory leukoencephalopathy associated with HAART-induced immune restoration in AIDS-related progressive multifocal leukoencephalopathy , 2005, Acta Neuropathologica.

[19]  I. Koralnik,et al.  New features of progressive multifocal leukoencephalopathy in the era of highly active antiretroviral therapy and natalizumab. , 2005, Journal of neurovirology.

[20]  F. Scaravilli,et al.  Central nervous system immune reconstitution disease in acquired immunodeficiency syndrome patients receiving highly active antiretroviral treatment. , 2005, Journal of neurovirology.

[21]  A. De Luca,et al.  Fatal inflammatory AIDS-associated PML with high CD4 counts on HAART: A new clinical entity? , 2004, Neurology.

[22]  J. Rockstroh,et al.  Progressive Multifocal Leukencephalopathy in Patients on Highly Active Antiretroviral Therapy: Survival and Risk Factors of Death , 2004, Journal of acquired immune deficiency syndromes.

[23]  B. Eley,et al.  Progressive multifocal leukoencephalopathy after initiation of highly active antiretroviral therapy in a child with advanced human immunodeficiency virus infection: a case of immune reconstitution inflammatory syndrome. , 2004, The Pediatric infectious disease journal.

[24]  W. Schlote,et al.  Progressive multifocal leucoencephalopathy with unusual inflammatory response during antiretroviral treatment , 2003, Journal of neurology, neurosurgery, and psychiatry.

[25]  S. Shelburne,et al.  The immune reconstitution inflammatory syndrome. , 2003, AIDS reviews.

[26]  G. Morahan,et al.  Polymorphisms in cytokine genes define subpopulations of HIV-1 patients who experienced immune restoration diseases , 2002, AIDS.

[27]  A. Safdar,et al.  Fatal immune restoration disease in human immunodeficiency virus type 1-infected patients with progressive multifocal leukoencephalopathy: impact of antiretroviral therapy-associated immune reconstitution. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[28]  A. J. Wright,et al.  Cidofovir treatment of progressive multifocal leukoencephalopathy in a patient receiving highly active antiretroviral therapy. , 2001, Mayo Clinic proceedings.

[29]  J. Cosín,et al.  Inflammatory reactions in progressive multifocal leukoencephalopathy after highly active antiretroviral therapy. , 2001, AIDS.

[30]  M. Lederman,et al.  Placebo-controlled trial of prednisone in advanced HIV-1 infection , 2001, AIDS.

[31]  A. De Luca,et al.  The effect of potent antiretroviral therapy and JC virus load in cerebrospinal fluid on clinical outcome of patients with AIDS-associated progressive multifocal leukoencephalopathy. , 2000, The Journal of infectious diseases.

[32]  J. Collazos,et al.  Contrast-enhancing progressive multifocal leukoencephalopathy as an immune reconstitution event in AIDS patients. , 1999, AIDS.

[33]  C. Fichtenbaum,et al.  Progressive multifocal leukoencephalopathy in patients with AIDS receiving highly active antiretroviral therapy. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[34]  D M Simpson,et al.  HAART improves prognosis in HIV-associated progressive multifocal leukoencephalopathy , 1999, Neurology.

[35]  T. W. Smith,et al.  Enhancing progressive multifocal leukoencephalopathy: an indicator of improved immune status? , 1998, The American journal of medicine.

[36]  R. Levy,et al.  Predictive factors for prolonged survival in acquired immunodeficiency syndrome—associated progressive multifocal leukoencephalopathy , 1998, Annals of neurology.

[37]  B. Gazzard,et al.  New treatments for progressive multifocal leukoencephalopathy in HIV-1-infected patients. , 1998, AIDS.

[38]  S. Kenney,et al.  Subclinical central nervous system infection with JC virus in patients with AIDS. , 1992, The Journal of infectious diseases.

[39]  C. Kufta,et al.  Involvement of JC virus-infected mononuclear cells from the bone marrow and spleen in the pathogenesis of progressive multifocal leukoencephalopathy. , 1988, The New England journal of medicine.

[40]  M. Post,et al.  Progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. A review of the literature with a report of sixteen cases. , 1987, Annals of internal medicine.